Is interleukin-6 a gender-specific risk factor for liver cancer?
September 27, 2007 7:38 pm factor, liver, risk, gender, interleukin, cancer
Hepatocellular carcinoma (HCC), the most common liver cancer, occurs mainly in men. Similar gender disparity is seen in mice given a chemical carcinogen, diethylnitrosamine (DEN). DEN administration caused greater increases in serum interleukin-6 (IL-6) concentration in males than it did in females. Furthermore, ablation of IL-6 abolished the gender differences in hepatocarcinogenesis in mice. DEN exposure promoted production of IL-6 in Kupffer cells (KCs) in a manner dependent on the Toll-like receptor adaptor protein MyD88, ablation of which also protected male mice from DEN-induced hepatocarcinogenesis. Estrogen inhibited secretion of IL-6 from KCs exposed to necrotic hepatocytes and reduced circulating concentrations of IL-6 in DEN-treated male mice. We propose that estrogen-mediated inhibition of IL-6 production by KCs reduces liver cancer risk in females, and these findings may be used to prevent HCC in males.
Full Research Data :
New Cancer Research
tramadolplus blog » Blog Archive » Is interleukin-6 a gender-specific risk factor for liver cancer? :
Date: January 23, 2008 @ 2:17 pm
[…] greater increases in serum interleukin-6 (IL-6) concentration in males than it did in females.read more | digg […]